TrialThe oncologist2011

Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer.

David Miles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.